Related by context. All words. (Click for frequent words.) 66 CAMPATH 65 LUMINATE 65 WILEX 64 Aloxi injection 64 MIVI TRUST 63 Pharma Medica 62 ALN PCS 62 HCV protease inhibitor 62 TG MV 62 glucokinase activator 62 immatics 62 Zenvia ™ 62 clinical pharmacology studies 62 CHAMPION PCI 62 lexidronam injection 62 Urocidin TM 62 REG1 62 trastuzumab DM1 T DM1 62 Androxal TM 61 JAK inhibitor 61 Nonclinical 61 ASPIRE HIGHER 61 ALN HPN 61 Bicifadine 61 GHIS 61 Curacyte 61 BrachySil TM 61 Embolic Protection Device 61 Myocet 61 PRESEPT Study 61 THALOMID 61 Hedgehog antagonist 61 Neuradiab 61 PEG SN# 61 PRECISE trial 61 ularitide 61 ACRIN 61 Phase Ib study 61 HDL Selective Delipidation 61 Onalta TM 61 Celmed 60 PREOS R 60 APTIVUS 60 OraTest R 60 QUADRAMET R 60 PDE# inhibitors 60 elbion 60 Urocortin 2 60 MGd 60 YONDELIS 60 RenalGuard System TM 60 Shigamabs ® 60 Azedra 60 INTEGRILIN 60 AutoloGel tm 60 Attrius ® 60 CINTREDEKIN BESUDOTOX 60 targeted radiotherapeutic 60 EndoTAG TM 60 STRIDE PD 60 Phase #b/#a clinical 60 Medidur FA 60 PSMA ADC 60 Onrigin TM 60 Ketotransdel 59 fosbretabulin 59 rxRNA 59 BUPHENYL R 59 Factor VIIa 59 lorcaserin Phase 59 Thorough QT 59 REVEAL Registry 59 LibiGel ® Phase III 59 elotuzumab 59 INTERCEPT platelets 59 Nitec 59 Proellex TM 59 TASKi2 59 UVIDEM 59 Prednisporin 59 Neovasc Reducer 59 Phase Ib II 59 SinuNase ™ 59 clevidipine 59 oral ridaforolimus 59 EndoTAG TM -1 59 Pertuzumab 59 herpetic keratitis 59 Fibrillex TM 59 inhibitor RG# 59 Trofex 59 phase IIa clinical 59 BioGeneriX 59 Panzem ® 59 Axentis Pharma 59 ESBATech 59 PRIALT 59 Increlex R 59 PDE4 inhibitor 59 phase IIb clinical 59 Phase IIB 59 Acute Ischemic Stroke 59 gastrointestinal malignancies 59 Onco TCS 59 Acute Decompensated Heart Failure 59 photodisinfection 59 BioSante LibiGel Phase III 59 CIMZIA ™ 59 BLA filing 59 research anddevelopment 59 preclinical efficacy 59 MAGE A3 ASCI 59 rhMBL 59 Solazed 59 ICAEL 59 Phase IIa trials 59 Miracor 59 sargramostim 59 Zenvia Phase III 59 Somatuline R Depot 59 UPLYSO 58 recombinant factor VIIa 58 PRESEPT 58 eTag assays 58 Hyphanox 58 nalbuphine ER 58 investigational therapies 58 Pharnext 58 MEND CABG 58 Alvesco R 58 IMA# 58 Telatinib 58 Cardiotoxicity 58 brivaracetam 58 ZACTIMA 58 SUTENT ® 58 Protexia ® 58 Diabetic Macular Edema 58 GenPath 58 immunotherapeutic vaccine 58 ENMD # 58 MabThera rituximab 58 NABTT 58 RIGScan CR 58 eprotirome 58 miRview mets 58 Ellex 2RT 58 DF HCC 58 NADiA 58 cardio renal 58 AFRS TM 58 Tekmira LNP technology 58 Renal Cell Carcinoma RCC 58 forodesine 58 Zorbtive TM 58 Immunotherapeutic 58 OncoGel 58 VITAL Trial 58 Cutanea 58 samarium Sm 58 DeveloGen 58 IPL# 58 autologous platelet gel 58 CytoFabTM 58 IL# PE#QQR 58 Ridaforolimus 58 GIPET 58 GW# [003] 58 AGGRASTAT ® 58 Lung Rx 58 Serdolect ® 58 ER CHOP 58 RhuDex ® 58 LEUKINE 58 CTSAs 58 dextofisopam 58 NP2 Enkephalin 58 myelofibrosis polycythemia vera 58 Sidec 58 CCX# 58 sunitinib malate 58 phase IIIb 58 CompuFlo 58 TKM ApoB 58 opioid induced bowel dysfunction 58 Alocrest 58 PHX# 58 phase IIb trial 58 ProFibrix 58 Oncaspar 58 TASKi3 58 MEK inhibitor 58 INC# 58 Surfaxin LS 58 orally bioavailable mimics 58 MEND CABG II 58 Elocalcitol 58 TheraSphere R 58 mSEPT9 biomarker 58 Faropenem 58 AERx iDMS 58 AeroLEF TM 58 BLP# Liposome Vaccine 58 LHRH antagonists 58 Phase IIIb clinical 58 placebo controlled Phase III 58 Dacogen injection 58 AGGRASTAT R 58 Orqis Medical 58 Sanochemia 57 ADAGIO study 57 PLK1 SNALP 57 Nanobody ® 57 MelaFind R 57 CALGB 57 Vascular Wrap TM 57 thorough QT 57 Firazyr 57 Shigamabs R 57 HCD# [002] 57 rFSH 57 Phase IIIB IV 57 Investigator Initiated 57 Tumor Response 57 SmartChip TM Real 57 Phase Ib clinical 57 RSD# oral 57 SCHWARZ PHARMA 57 THR beta agonist 57 biostatistical analysis 57 Curacyte AG 57 BAL# [002] 57 CEQ# 57 ACOMPLIA R 57 GEM OS2 57 DUROS 57 ERYtech 57 Revotar 57 Civacir 57 cat dander allergy 57 EHT AGN 57 SYGNIS 57 budesonide MMX Phase III 57 MOZOBIL 57 GYN Surgical revenues 57 ATL# [001] 57 TheraCIM 57 HepaSphere 57 Phase IIb clinical trials 57 Nanobody 57 ThermoDox ® clinical 57 QTDP grant 57 Somatuline R Autogel R 57 Cleviprex TM clevidipine 57 mertansine 57 CAPHOSOL 57 tubulin inhibitor 57 Spiegelmer ® 57 Zemiva TM 57 NTDDS 57 Aurexis 57 Loramyc R 57 EndoTAG 57 DDP# 57 Nektar pulmonary 57 Trofex TM 57 histone deacetylase HDAC inhibitor 57 thetreatment 57 QTinno TM 57 HuLuc# 57 Vancocin R 57 Oasmia 57 including eniluracil ADH 57 Cerep 57 MYCAMINE 57 inhaled treprostinil 57 PROMUS Element Stent 57 Trophos 57 Cardiometabolic 57 AQ4N 57 ENDEAVOR clinical 57 Aurora kinase inhibitor 57 GLP toxicology 57 EGS# 57 DYNEPO 57 Dacogen decitabine 57 Avantra 57 PEGylated interferon 57 Squalamine 57 Aegera 57 Clolar ® 57 EOquin 57 uroNIRS 57 Solos Endoscopy 57 BioMarck 57 multicenter clinical trials 57 Azedra TM 57 Glypromate 57 PREGNANT Study 57 PROMETA protocols 57 plerixafor 57 MarginProbe 57 Fibrin Pad 57 angiographic outcomes 57 Guanilib 57 TYSABRI natalizumab 57 SNT MC# 57 Phase #b/#a 57 Eculizumab 57 OZURDEX 57 NeuroStar TMS Therapy 57 Virium 57 Bionate ® PCU 57 dextromethorphan quinidine 57 GRN# 56 AFFiRiS 56 candidate CRLX# 56 telaprevir VX 56 HIFU therapy 56 genotoxicity reproductive toxicology 56 AVONEX ® 56 ZEVALIN ® 56 TiGenix 56 Axiogenesis 56 Daxor 56 diarrhea predominant irritable 56 CRLX# 56 CR# vcMMAE 56 vidofludimus 56 OZURDEX ® 56 Tiuxetan 56 VIAject ™ 56 Betaferon R 56 NGFN 56 Personalized Oncology 56 vernakalant hydrochloride 56 Phase Ib Clinical Trial 56 haematological cancers 56 oral PTH 56 SILENOR 56 MoxDuo TM IR 56 cerebral oximetry 56 inhaled AAT 56 EP #R 56 Zybrestat 56 GI motility disorders 56 MYDICAR 56 zanolimumab 56 CB1 antagonists 56 MorphoSys proprietary 56 Anavex #-# 56 Symphony ViDA 56 CRMD# 56 solid organ transplantation 56 Amrubicin 56 Biomerk Tumorgrafts 56 Liprotamase 56 pertuzumab 56 octreotide implant 56 André Michel Ballester 56 OLYMPIA registry 56 TLK# 56 Randomized Evaluation 56 ONCONASE R 56 riociguat 56 budesonide foam 56 Prodarsan R 56 HuCAL antibody 56 MDxHealth 56 Zemplar Capsules 56 IV Busulfex 56 synthetic retinoid 56 CardioFit 56 Aryplase 56 Phase IIIb 56 CIMZIA TM certolizumab pegol 56 HuMax EGFr 56 Anticalin ® 56 recombinant FVIII 56 ALN TTR 56 rFactor XIII 56 RECOTHROM R 56 B2A 56 AMPAKINE CX# 56 histamine dihydrochloride 56 Myoblast 56 NeuroDiscovery 56 palifosfamide 56 PROSTASCINT R 56 ARIKACE ™ 56 Degarelix 56 Prodarsan ® 56 neratinib 56 Valdoxan 56 Ocrelizumab 56 NeedleTech 56 GLP toxicology studies 56 Sopherion 56 inVentiv Clinical 56 TRISENOX 56 miRview meso 56 Cloretazine ® 56 PDX pralatrexate 56 Exelixis XL# 56 Pimavanserin 56 XLTEK 56 Contura MLB 56 Lixivaptan 56 OvaRex R 56 Celacade TM 56 severe hypercholesterolemia 56 PORxin TM 56 DermTech International 56 AclarusDx ™ 56 Coronary stent 56 metastatic neuroendocrine tumors 56 Creabilis Therapeutics 56 Immunodiagnostic 56 Syntonix 56 AzaSite TM 56 HyACT 56 BIIR 56 Nuvion 56 Virulizin R 56 radiotherapeutic 56 Intarcia 56 Agennix Incorporated 56 StemEx R 56 Omthera 56 Metricath Gemini 56 QuadraSphere 56 CD# monoclonal antibody 56 Voraxaze ™ 56 OPTTX 56 Plenaxis TM 56 Oral NKTR 56 Tesmilifene 56 Octreolin 56 teriflunomide 56 ELACYT 56 HGS# 56 midstage clinical 56 RAPAFLO 56 gastrointestinal motility disorders 56 RELOVAIR ™ 56 Zosano 56 XP #L 56 ENDEAVOR IV 56 AZD# TC 56 CoFactor 56 cangrelor 56 Removab 56 pain palliation 56 Phase III randomized controlled 56 ERYtech Pharma 56 Chrysalin 56 G#DT 56 EchoCRT 56 Fentanyl TAIFUN R 56 MGCD# clinical trials 56 MoxDuo IR 56 registrational 56 Multiple Ascending Dose 56 Cardene ® 56 Bellicum 56 BrachySil ™ 56 CD# antibody [001] 56 Yondelis ® 56 TRO# 56 Onalta 56 TRISENOX ® 56 TG# [003] 56 LibiGel Phase III 56 Ganite ® 56 Plicator 56 EmbraceAC 56 lomitapide 56 Retisert 55 ExAblate R 55 BioSurgery 55 Allovectin 7 55 torsemide ER 55 BR.# 55 HepeX B 55 Catheter Ablation 55 GSK# [001] 55 Exforge HCT 55 Litx 55 adecatumumab 55 multimodality imaging 55 ACCLAIM 55 VEGF Trap 55 AFFITOME 55 Cx# [002] 55 Lytix 55 MitoKor 55 lumiliximab 55 Euroscreen 55 selective androgen receptor modulator 55 GLIADEL R 55 Arno Therapeutics 55 Catena ® 55 tesmilifene 55 SUTIMCo 55 Daclizumab 55 eTag assay 55 LB# [003] 55 immunological diseases 55 TQT 55 Clavis Pharma 55 HuMax 55 FDA Investigational Device 55 Current Controlled Trials 55 balsalazide tablet 55 SUCCEED trial 55 multicenter Phase II 55 prospective randomized multicenter 55 E1 INT TM 55 Fabry Disease 55 See CLINICAL PHARMACOLOGY 55 ALN RSV program 55 Evotec Neurosciences 55 ThinPrep System 55 TMS Therapy 55 Xillix 55 Chemokine 55 Endeavor DES 55 XIENCE V Everolimus Eluting 55 atherogenic dyslipidemia 55 enzastaurin 55 ISTO 55 inhalation toxicology 55 NCCN Compendium 55 Dextofisopam 55 patented Bioral 55 custirsen 55 novel oral anticoagulant 55 Ranolazine 55 Increlex ® 55 tanespimycin 55 constipation OIC 55 pradefovir 55 postapproval 55 Medidur 55 AutoloGel tm System 55 Hepatocellular Carcinoma HCC 55 PROMETA ® 55 ALISTA 55 Spirus Medical 55 Elitek 55 reslizumab 55 ATryn ® 55 Infergen R 55 atacicept 55 FVIIa 55 receptor tyrosine kinase inhibitor 55 Chemophase 55 Sunesis Pharma 55 Option IVC Filter 55 FOLOTYN ® 55 RE LY ® 55 JUVISTA 55 Emphasys 55 InterfeRx 55 phase IIb 55 Restanza TM 55 phase IIb III 55 Cloretazine R VNP#M 55 WavSTAT 55 Aflibercept 55 Velcade bortezomib 55 sJIA 55 daptomycin 55 NCCTG 55 Selexis 55 EDEMA3 55 Glatiramer acetate 55 busulfan 55 Phase 2b kidney transplant 55 NanoKnife IRE System 55 IMC #B 55 Genedata Screener 55 alvimopan 55 Virulizin ® 55 Lauren Silvernail 55 topically applied SEPA 55 aerosolized KL4 surfactant 55 AtherOx 55 HeFH 55 Deforolimus 55 Jerini 55 ALGRX 55 Mipomersen 55 Caris MPI 55 Hemolung 55 EECP R 55 Vantia Therapeutics 55 CLARITY study 55 EyeGate 55 motesanib diphosphate 55 REMEDI 55 Progentix 55 PFO migraine 55 Dr. Yatscoff 55 tiapamil 55 Src inhibitors 55 GRAVITAS trial 55 Rezular 55 intravesical infusion therapy 55 Trofex ™ 55 Ixempra 55 ThinPrep Pap Test 55 Leukine ® 55 Certican 55 platelet gel 55 Trandolapril 55 Neoadjuvant Chemotherapy 55 prelicensure 55 ALTROPANE 55 VTE prevention 55 NextPharma 55 HER2 overexpression 55 BioSTAR R 55 ImmuKnow R 55 NovaScreen 55 CANCIDAS 55 AltaRex 55 Cardene R 55 Imaging Diagnostic 55 Plenaxis R 55 AQUAVAN R 55 ADVANCE PD 55 EVIZON TM squalamine lactate 55 BEMA TM Fentanyl 55 ASSERT 55 Sylvie Gregoire President 55 Nanobodies ® 55 vinca alkaloid 55 preclinically 55 R#/MEM 55 Phase IIb III 55 Insert Therapeutics 55 Nanobody R 55 ThromCat 55 Traficet EN 55 aflibercept 55 trodusquemine 55 TEMSO 55 acute coronary syndromes ACS 55 antiangiogenic agents 55 RGB # 55 Abbokinase 55 Intravenous CP 55 product Fentanyl TAIFUN 55 Translational Science Award 55 ProstaScint 55 outlicensing 55 Thrombin 55 stage hypoxia activated 55 Ziopharm 55 Cimzia ® certolizumab pegol 55 StemEx 55 JAK inhibitors 55 Sulonex TM 55 Fenoglide 55 TORISEL 55 TBC# 55 MOVIPREP R 55 Neupogen ® 55 epoetin alpha 55 Triolex 55 Ascend Therapeutics 55 EnVivo 55 MediClin 55 NV1FGF 55 HepDirect prodrug 55 ARCALYST ® 55 Pulmonary Arterial Hypertension 55 PRADAXA 55 Troxatyl 55 Olmesartan 55 ToGA 55 Ozurdex 55 Radioimmunotherapy 55 GAMMAGARD 55 Frova ® 55 hemofiltration 55 COSIRA trial 55 BCIRG 55 haematological malignancies 55 Meta analyzes 55 direct thrombin inhibitors 55 Triapine R 55 deforolimus 55 Bezielle 55 abstracts summarizing 55 CHARM Added 55 Angioblast 55 AA Amyloidosis 55 JAK2 inhibitor 55 PyratineXR 55 fibromyalgia syndrome 55 Fresenius Biotech 55 ZEFTERA TM Zevtera TM 55 Scil Proteins 55 Procoralan 55 obatoclax 55 somatostatin analogues 55 Ceflatonin R 55 topical ophthalmic 55 XmAb 55 beta 1a 55 PrevOnco 55 Cerashield TM 55 cathepsin K inhibitor 55 OvaRex 55 sodium thiosulfate STS 55 RE LY 55 AIM HIGH 54 preclinical toxicology 54 Max Neeman 54 Cloretazine 54 Actimmune ® 54 plus DOXIL 54 CRVO 54 NeuroSTAT ® 54 Opsona 54 BACcel 54 Altastaph 54 K DOQI guidelines 54 GERD migraine headaches 54 European Sepsis Trial 54 CLIRS trial 54 INS# [001] 54 Paromomycin 54 NSABP 54 plasma kallikrein inhibitor 54 candidates Dyloject TM 54 Ophthotech 54 depsipeptide 54 IoGen 54 ResponseDX 54 Fodosine 54 HDAC Inhibitor 54 OvaRex ® MAb 54 Valsartan 54 TGR5 54 TACI Ig 54 SurModics Pharmaceuticals 54 metaglidasen 54 Phase IIIb study 54 SPRIX ® 54 GSK# [002] 54 Ivivi 54 OMAPRO 54 OLUX 54 ASGCT 54 Xanafide 54 Vernakalant 54 oncological indications 54 PROLARIS 54 DACH platinum 54 Neurobionix division 54 genomic biomarker 54 TCGA Pilot Project 54 Dialysis Outcomes 54 cardiovascular metabolic 54 Ulrich Dauer CEO 54 preclinical pharmacokinetic 54 Functional Dyspepsia 54 dorzolamide 54 Aquinox 54 Heartscape Technologies 54 CINtec R 54 PORxin TM platforms 54 Strativa 54 alemtuzumab MS 54 bevirimat Study 54 exploratory endpoints 54 Onconase 54 MastaScope 54 Icatibant 54 Phase 1b trial 54 kidney urologic 54 MERREM IV 54 Xyfid TM 54 AZASITE 54 diagnostic radiopharmaceutical 54 tipranavir 54 celgosivir 54 INTEGRILIN R eptifibatide Injection 54 DAPT Study 54 ONTAK 54 ibudilast 54 alvespimycin 54 Serious Adverse Events 54 LibiGel ® 54 HuMax HepC TM 54 micafungin 54 Diabetic Neuropathy 54 MERLIN TIMI 54 Fragment Library 54 Mucopolysaccharidosis 54 comminution circuit 54 Electronic Brachytherapy 54 PAION AG 54 INOmax R 54 POTELLIGENT ® 54 YONDELIS R 54 Bellicum Pharmaceuticals Inc. 54 Dalbavancin 54 CA9 SCAN 54 Ereska 54 EUR#.#million 54 Interagency Registry 54 Domilens 54 Dr. Pingpank 54 FACTIVE tablets 54 Rilonacept 54 Circulatory Support 54 ACTILON 54 Veronate 54 ThermoDox R 54 SANVAR 54 ACCLAIM II 54 multicenter randomized clinical 54 orthoPACE 54 TH# [003] 54 novel histone deacetylase 54 velafermin 54 personalized cellular immunotherapy 54 Nascobal ® 54 GSK '# 54 embolotherapy 54 Cellegesic 54 ITAX 54 dose escalation phase 54 IGF 1R inhibitor 54 AERx ® 54 EVICEL 54 Indivumed 54 Fentanyl Taifun 54 null responder 54 postoperative ileus POI 54 multimodality therapy 54 Prostate Px + 54 HepaMate 54 punctal plug delivery 54 Vascugel ® 54 Medifacts 54 Adaptive Radiation Therapy 54 NeuroFlo 54 Miikana 54 XP# XP# 54 Computed Tomographic 54 CYT# potent vascular disrupting 54 sulodexide 54 Aggrenox ® 54 Enkephalin 54 Edwards SAPIEN valve 54 IVMD 54 BioControl 54 Curon Medical 54 dacetuzumab 54 reaZin 54 myocardial revascularization 54 Tarmogen 54 relapsing multiple sclerosis 54 QTDP 54 ASX PGL 54 GED aPC 54 systemic immunosuppressive drugs 54 CoAxia 54 Phase III Clinical Trial 54 R#/MEM # 54 BCR ABL inhibitors 54 Proxinium TM 54 Zevalin consolidation 54 HQK 54 Hemopurifier ® 54 GEM #S 54 Rebif ® 54 FlexStent ® 54 ISTH 54 TriActiv R 54 AION Diagnostics 54 enzyme immunoassay EIA 54 ISTODAX 54 JenaValve 54 BeneFIX 54 Capsulution 54 Acute Coronary Syndromes 54 CD3 monoclonal antibody 54 Cardioxyl 54 ARCALYST ® rilonacept 54 dosimetric 54 bioresorbable stent 54 Catheter Associated 54 Heap Leach Project 54 prospective multicenter study 54 tolevamer 54 trastuzumab DM1 54 MYTHOS trial 54 GOUT 54 Phase 1b clinical trials 54 teduglutide 54 Neosil 54 OvaRex MAb 54 HartLab 54 Curidium 54 cannabinor 54 Intraject 54 BioNumerik 54 LiDCO 54 randomized Phase IIb 54 HalcyGen 54 Prospective Randomized 54 Mepact 54 faropenem 54 TandemHeart System 54 NATRECOR R 54 phase IIa 54 CyberKnife Radiosurgery 54 PhG alpha 1 54 Cathepsin S 54 ambulatory infusion pumps 54 Antithrombin 54 AEG# 54 Mestinon 54 NovaVision VRT 54 CEVEC 54 stable nucleic acid 54 carotid artery stent 54 Neulasta ® 54 Aureon 54 goBalto 54 solithromycin 54 EOquin TM 54 NovaBay Aganocide compounds 54 Diatos 54 Apixaban 54 MORAb 54 DAPT 54 RESOLUTE clinical 54 ENGAGE AF TIMI 54 PsychoGenics 54 AzaSite Plus 54 Targretin capsules 54 Infarct 54 Convergent Procedure 54 anti CD# antibodies 54 RITUXAN 54 Photodisinfection System 54 GI endoscopy 54 PCI Biotech 54 M6G 54 NeuroSolutions 54 tranilast 54 ALN TTR# 54 phase III ACCLAIM 54 DermaVir Patch 54 Quinamed 54 PARI Pharma 54 benign prostatic hypertrophy BPH 54 Rapaflo 54 Medidur TM 54 Anticalins ® 54 Embolic Protection 54 Argatroban 54 Evoltra 54 MIST II 54 Surgical Treatment 54 chronic myocardial ischemia 54 glatiramer 54 PD2i CA 54 ONTARGET 54 pharmacokinetic PK study 54 favorable pharmacokinetic profile 54 ORENCIA R 54 ATL/TV# 54 BiTE 54 catheter occlusion 54 viral kinetics 54 FRDA 54 ONTARGET R 54 Emisphere Technologies 54 Liprostin 54 MVax 54 Critical Limb Ischemia CLI 54 MoxDuo ® 54 Acthar Gel 54 immunotherapy treatments 54 Alzhemed TM 54 CXA 54 DOXIL 54 Dr. Stylli 54 Ecallantide 54 Nasdaq PARD biopharmaceutical 54 IV acetaminophen